👉High Lp(a): Actionable strategies for risk assessment and mitigation

☝️This review focuses on the identification and clinical management of patients with high Lp(a).
Specifically, the authors highlight the clinical value of measuring Lp(a) and its use in determining Lp(a)…

😍Love my place
#amardelplata

☝️Please stop talking about the “Lipid Hypothesis”

There is no such thing

👉It's an incorrect and outdated way to refer to the CAUSAL relationship between LDLc (ApoB) and Atherosclerosis (CHD)

European Atherosclerosis Society

👉There are alternative methods to test the 'LMHR hypothesis,' such as a tracer study in the laboratory.

☝️It would be unethical to expose individuals to very high LDL-C or ApoB levels, given the multiple lines of evidence indicating that these risk factors CAUSE…

👉 Aspirin Use for Primary Prevention Among US Adults With and Without Elevated Lp(a)

☝️Regular aspirin use was associated with a 52% lower risk of ASCVD mortality among adults without clinical ASCVD who had elevated Lp(a).
These findings suggest that measurement of Lp(a) may…

🤩
Love #Vallarta and 🇲🇽

🙌Just one month away from the world's largest event on Atherosclerosis and Cardiovascular Prevention.
Don't miss the opportunity to learn, share, and enjoy the #EAS2024

👇👇👇
eas-congress.com/2024/

Atherosclerosis, the number one killer worldwide, begins much earlier than when it can be detected by coronary artery calcium (CAC) score

👉The current landscape for diabetes treatment: Preventing diabetes-associated CV risk

👏A must read manuscript

1️⃣ Subjects with type 2 diabetes have a substantial excess of atherosclerotic cardiovascular disease (ASCVD)-related events.

2️⃣ The understanding of the…

🙌 People matter!

Prof Kausik Ray FMedSci

Muchas gracias Funcolehf ☺️
Un placer seguir trabajando para mejorar la vida de los pacientes con #SQF #FCS

👉Remnant cholesterol, LDLc, and apoB absolute mass changes explain results of the PROMINENT trial

☝️Absolute mass changes in remnant cholesterol, LDL cholesterol, and apolipoprotein B can explain results of the PROMINENT trial. The 3mg/dL (0.08mmol/L) higher total atherogenic…

🤩Happy to be part of this amazing meeting in Colombia 🇨🇴

👉“Severe HTG and different scenarios”

Asociación Colombiana de Endocrinología, Diabetes y Metabolismo

🤔“Is there any association between TC, TG, LDLc and Lp(a) levels in childhood/adolescence and CV events in adulthood?”

☝️Find the answer in our last article, just published

👉Association between lipid markers in childhood/ adolescence and CV events in adulthood: A systematic…

👉Modification of lipoprotein metabolism and function driving atherogenesis in diabetes

☝️ Inference of clinical intervention studies identify the number of ApoB-containing lipoproteins as a stronger driver of the pathological processes resulting in clinical outcomes than their…

👏Excellent article; a must read!

👉Lipid-Lowering Therapy after Acute Coronary Syndrome

☝️There is a sufficient amount of evidence that the immediate combination of LLT after ACS leads to early LDL-C goal achievement without any safety concerns. On top of it, intensive LLT…

👉Atherosclerosis evaluation and CV risk estimation using CCTA

☝️The direct disease visualization of CCTA has the potential to be used synergistically with indirect markers of risk to significantly improve prevention of MACE, pending large-scale randomized evaluation.

🔓Open…

👉What Causes Premature Coronary Artery Disease?

😳Could you explain why this review doesn't mention Lp(a) even once?

🤦🏻It also confusingly mixes risk factors, risk markers, enhancers, and other elements when discussing 'causes'

link.springer.com/journal/11883/…